Eckhardt Sue Gail
- SEC CIK
- 0001823769
In the past year, 2 open-market sale filings worth $660.8K and no purchases.
Current role at each company
- EXEL Exelixis, Inc.Directoras of Jun 3, 2026
- SYRS Syros Pharmaceuticals, Inc.Directoras of Jun 7, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $660.8K
- 2 filings
- Net
- −$660.8K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Eckhardt Sue Gail as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EXEL Exelixis, Inc.
Director4 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2026 (view filing) | Jun 1 | 2 days | Eckhardt Sue GailDirector | SSale | −9.81K | $50.14 | −$492.0K | −37.9%16.1K after | 10b5-1 |
| Feb 18, 2026 (view filing) | Feb 13 | 5 days | Eckhardt Sue GailDirector | SSale | −3.86K | $43.79 | −$168.9K | −18.0%17.5K after | 10b5-1 |
| Jun 4, 2025 (view filing) | Jun 2 | 2 days | Eckhardt Sue GailDirector | SSale | −18.8K | $42.74 | −$805.1K | −46.8%21.4K after | 2 lots10b5-1 |
| Feb 19, 2025 (view filing) | Feb 14 | 5 days | Eckhardt Sue GailDirector | SSale | −11.6K | $35.02 | −$405.1K | −27.6%30.4K after | 2 lots10b5-1 |